Horizon to license haploid models to Abcam in deal worth up to $3m
Horizon Discovery, a UK CRO, will license its cell lines to Abcam for use validating antibodies for up to $3m.
Archives for September 8, 2015
GSK starts work on $153m anti inflammatories and gastro drug plant in India
GSK has started work on an anti-inflammatory and gastrointestinal drug production plant in Vemgal, India which will create 300 manufacturing jobs.
Horizon attempts $1.68bn hostile bid for Depomed
Horizon Pharma has renewed its efforts to take over pain and neurology firm Depomed for approximately $1.68bn (€1.5bn).
Putin: Industry must back Russia's 90% domestic drugmaking target
Vladimir Putin says support from Russian business community is needed to help achieve the domestic drug manufacturing goals set out in his Pharma 2020 policy.
Lubrizol buys Particle Sciences to build in device and formulations contracting space
Berkshire Hathaway-owned Lubrizol has bought drug formulation and device contractor Particle Sciences.
Aragen Bioscience licenses protein yield boosting tech for cell line development
ProteoNic Biotechnology BV has licensed its protein production technology to US contractor Aragen Bioscience.
Genticel granted US patent for cancer vaccine delivery tech
Vaccine developer Genticel has been granted a US patent protecting the use of CyaA-based antigen delivery vectors in combination cancer therapies.